Information

Goals and Mission
The North American Research Committee On Multiple Sclerosis (NARCOMS) Project was initiated in 1993 by the Consortium of Multiple Sclerosis Centers. The project is led by Dr. Tim Vollmer, an international leader in multiple sclerosis care, immunology, and MS research.  NARCOMS has developed an MS Patient Registry that is the largest of its kind in the world. The primary purpose of the NARCOMS project is to facilitate multi-center research in the broad field of Multiple Sclerosis. Collaboration between centers of excellence in Multiple Sclerosis is essential for rapid progress in the development of better treatments for MS and for greater understanding of the disease.

As of March 2010, the number of Registry enrollments has reached 35,000 and new participants are joining everyday. Convenient online enrollment for anybody diagnosed with MS is available at this website(Enroll online)

Individuals with Multiple Sclerosis who enroll in the NARCOMS Registry receive the printed version of the Multiple Sclerosis Quarterly Report (MSQR) four times a year. This journal is free of charge and includes original review articles, NARCOMS news, breaking news, as well as listings of clinical trials in progress and open for enrollment.

We hope that the MSQR will keep you abreast of recent findings and studies of interest. Samples of past issues of the MSQR are available electronically.

We encourage medical professionals in the field of Multiple Sclerosis to become involved in developing materials for the MSQR. Please contact NARCOMS if you are interested in authoring a review paper.

Support/Funding
NARCOMS is a project of the Consortium of Multiple Sclerosis Centers and is supported by grants and in-kind services from United Spinal Association, Paralyzed Veterans Association (PVA), and the National Multiple Sclerosis Society. Additional support has been provided by unrestricted grants from the following pharmaceutical companies: Bayer Pharmaceuticals, Inc., EMD Serono, and TEVA Neuroscience.